Journals / Journal of Health Sciences and Management / 2022 / Cilt: 2 - Sayı: 1

LİMİTATİONS OF NEUROLOGİCAL INFLUENCES İN TERMS OF PULMONARY REHABİLİTATİON APPROACHES İN POST-COVID-19

Post-COVID-19’da Nörolojik Etkilenimlerin Pulmoner Rehabilitasyon Yaklaşımları Açısından Kısıtları

Pages
20–26
Publication Date
2022-01-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Considering the rehabilitation constraints according to the common neurological involvement in COVID-19 patients is clinically important for the success of the application.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim of this study is to determine the limitations of pulmonary rehabilitation interventions applied in COVID-19 in the neurological involvement.
📊
Key Findings & Data:Articles between December 2019 and June 2021 were scanned without any language restrictions.
💡
Conclusion & Impact:Considering the rehabilitation constraints according to the common neurological involvement in COVID-19 patients is clinically important for the success of the application.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:COVID-19 · nörolojik etkilenim · yorgunluk

Abstract

Aim of this study is to determine the limitations of pulmonary rehabilitation interventions applied in COVID-19 in the neurological involvement. Relevant studies were identifed through electronic explorations of PubMed, Google Scholar, Cochrane, PEDro and CINAHL. Articles between December 2019 and June 2021 were scanned without any language restrictions. Databases were selected in accordance with the MeSH evaluation criteria for terms related to SARS-CoV-2/COVID 19, neurological manifestations and treatment. Headache, dizziness, taste and smell dysfunctions, and impaired consciousness were the most frequently described symptoms. Besides, after infection, stroke, Guillain-Barre Syndrome, ataxia, polyneuropathy/myopathy, and encephalopathy are also common. Also, infection increases mortality and morbidity rates in individuals who have had a neurological history prior to infection. Patients with neurological involvement should avoid high-intensity exercise programs, especially in the symptoms of fatigue and exercise intolerance. Considering the rehabilitation constraints according to the common neurological involvement in COVID-19 patients is clinically important for the success of the application.

Özet

Bu çalışmanın amacı, COVID-19 sonrası nörolojik etkilenimin de eşlik ettiği durumda pulmoner rehabilitasyon uygulamaları açısından oluşturduğu kısıtları ortaya koymaktır. İlgili çalışmalar, PubMed, Google Scholar, Cochrane, PEDro ve CINAHL veritabanlarında elektronik aramayla belirlenmiştir. Aralık 2019-Haziran 2021 tarihleri arasındaki makaleler herhangi bir dil kısıtlaması uygulanmadan taranmıştır. Veritabanlarında SARS-CoV-2/COVID-19, nörolojik etkilenimler ve tedavileri ile ilgili terimler MeSH değerlendirme kriterlerine uygun olarak seçilmiştir. Baş ağrısı, baş dönmesi, tat ve koku bozuklukları ve konfüzyon en sık tanımlanan semptomlardır. Yanısıra inme, Guillain-Barre Sendromu, ataksi, polinöropati/miyopati ve ensefalopati de enfeksiyon sonrası klinik tabloda görülmektedir. Ayrıca enfeksiyon öncesi nörolojik hikayesi bulunan hastalarda enfeksiyonla birlikte mortalite ve morbidite oranları da artmaktadır. Nörolojik etkilenimli hastalarda özellikle yorgunluk ve egzersiz intoleransı semptomlarında yüksek şiddetli egzersiz programlarından kaçınılmalıdır. COVID-19 hastalarında sık görülen nörolojik etkilenime göre rehabilitasyon kısıtlarının dikkate alınması uygulama başarısı açısından klinik anlamda önemlidir.

🔖

Cite This Article

KIZKIN, Z. Y., YURDALAN, U. (2022). LİMİTATİONS OF NEUROLOGİCAL INFLUENCES İN TERMS OF PULMONARY REHABİLİTATİON APPROACHES İN POST-COVID-19. Journal of Health Sciences and Management, Cilt: 2 - Sayı: 1, 20–26. https://ajindex.com/articles/835714

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13.
  2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.
  3. Ribeiro R, Brandão D, Noronha J, Lima C, Fregonezi G, Resqueti V, et al. Breath-stacking and incentive spirometry in Parkinson's disease: Randomized crossover clinical trial. Respir Physiol Neurobiol. 2018;255:11-6.
  4. Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24(2):168-75.
  5. Abdullahi A, Candan SA, Abba MA, Bello AH, Alshehri MA, Afamefuna Victor E, et al. Neurological and Musculoskeletal Features of COVID-19: A Systematic Review and Meta-Analysis. Front Neurol. 2020;11:687. Esler M, Esler D. Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic? J Hypertens. 2020;38(5):781-2.
  6. Doblan A, Kaplama ME, Ak S, Basmacı N, Tarini EZ, Göktaş Ş E, et al. Cranial nerve involvement in COVID-19. Am J Otolaryngol. 2021;42(5):102999. Yong SJ. Persistent Brainstem Dysfunction in Long-COVID: A Hypothesis. ACS Chem Neurosci. 2021;12(4):573-80.
  7. Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, et al. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. N Engl J Med. 2020;382(20):e60. Alberti P, Beretta S, Piatti M, Karantzoulis A, Piatti ML, Santoro P, et al. Guillain-Barré syndrome related to COVID-19 infection. Neurology - Neuroimmunology Neuroinflammation. 2020;7(4):e741. Camdessanche JP, Morel J, Pozzetto B, Paul S, Tholance Y, Botelho-Nevers E. COVID-19 may induce Guillain-Barré syndrome. Rev Neurol (Paris). 2020;176(6):516-8.
  8. Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. Guillain-Barré Syndrome Associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574-6.
  9. Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020;19(5):383-4.
  10. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829-38.
  11. Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 Virus Targeti